Vexa
NDC Package 49430-053-15

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Vexa is clean and dry affected areaRemove mesh from backing and apply to affected areaUse only one mesh at a time, and maximum of four mesh/dayLeave mesh on affected area for up to 8 hoursDo not use mesh for longer than five consecutive daysChildren under 12 should consult physician prior to use. Marketed by Pharmaceutics Corporation, this product is identified by NDC 49430-053.

Identification & Billing

NDC Package Code
49430-053-15
Package Description
3 POUCH in 1 BOX / 5 PATCH in 1 POUCH
Product Code
49430-053
11-Digit Billing Format
49430005315
RxNorm Crosswalk
  • RxCUI: 1540663 - allantoin 2 % / lidocaine 4 % / petrolatum 30 % Medicated Patch
  • RxCUI: 1540663 - allantoin 0.02 MG/MG / lidocaine 0.04 MG/MG / petrolatum 0.3 MG/MG Medicated Patch
  • RxCUI: 1540669 - Vexa-D 2 % / 4 % / 30 % Medicated Patch
  • RxCUI: 1540669 - allantoin 0.02 MG/MG / lidocaine 0.04 MG/MG / petrolatum 0.3 MG/MG Medicated Patch [Vexa]
  • RxCUI: 1540669 - Vexa (allantoin 2 % / lidocaine 4 % / petrolatum 30 % ) Medicated Patch

Clinical Specifications

Proprietary Name
Vexa
Dosage Form
-
Usage Information
Clean and dry affected areaRemove mesh from backing and apply to affected areaUse only one mesh at a time, and maximum of four mesh/dayLeave mesh on affected area for up to 8 hoursDo not use mesh for longer than five consecutive daysChildren under 12 should consult physician prior to use

Regulatory & Marketing

Labeler Name
Pharmaceutics Corporation
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
03-19-2015
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49430-053-15 identifies a specific commercial package of 3 pouch in 1 box / 5 patch in 1 pouch of Vexa, labeled by Pharmaceutics Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pharmaceutics Corporation on March 19, 2015. The current certification is valid through December 31, 2017.

How is this Pharmaceutics Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49430005315. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49430-053-15
11-Digit CMS (5-4-2)
49430-0053-15

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.